全球研發(fā)行業(yè)市場前景及投資研究報告-培訓(xùn)課件外文版2024.6工業(yè)機(jī)器人優(yōu)必選_第1頁
全球研發(fā)行業(yè)市場前景及投資研究報告-培訓(xùn)課件外文版2024.6工業(yè)機(jī)器人優(yōu)必選_第2頁
全球研發(fā)行業(yè)市場前景及投資研究報告-培訓(xùn)課件外文版2024.6工業(yè)機(jī)器人優(yōu)必選_第3頁
全球研發(fā)行業(yè)市場前景及投資研究報告-培訓(xùn)課件外文版2024.6工業(yè)機(jī)器人優(yōu)必選_第4頁
全球研發(fā)行業(yè)市場前景及投資研究報告-培訓(xùn)課件外文版2024.6工業(yè)機(jī)器人優(yōu)必選_第5頁
已閱讀5頁,還剩38頁未讀, 繼續(xù)免費閱讀

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進(jìn)行舉報或認(rèn)領(lǐng)

文檔簡介

INDUSTRIES

&

MARKETSResearchanddevelopment(R&D)worldwideCHAPTER

01GlobalR&DspendingTotalglobalspendingonresearchanddevelopment(R&D)from1996to2022(inbillionU.S.dollars)TotalglobalR&Dspending1996-20223,0002,5002,0001,5001,0002,348.22,232.571,969.421,824.381,628.311,433.931,319.051,111.55923.73821.73740.78624.64555.0550004Description:Researchanddevelopment(R&D)spendingwasforecasttoreachover2.47trillionU.S.dollarsgloballyin2022(oncelocalcurrenciesareconvertedforpurchasingpowerparity).ThiscomparestoaroundonetrillionU.S.dollarsin2005,andaround555billionU.S.dollarsin1996.Spendingdecreasedsomewhatin2020followingtheoutbreakofCOVID-19,butincreasedagainin2021andwasforecasttodosoin2022too.

ReadmoreNote(s):Worldwide;1996to2022Source(s):R&DWORLD;UNESCOInstituteforStatisticsGrossdomesticspendingonresearchanddevelopment(R&D)inG7countriesandChinafrom2000to2022,bycountry(inbillionU.S.dollars)GrossdomesticR&DspendinginG7countriesandChina2000-2022CanadaChinaFranceGermanyItalyJapanUnitedKingdomUnitedStates80070060050040030020010002000

2001

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

20225Description:In2020,grossdomesticspendingonresearchanddevelopment(R&D)inChinacameclosestthatoftheUnitedStates,reaching563.3billionU.S.dollars,comparedto672billionU.S.dollarsintheUnitedStates.Inthatyear,Japancameadistantthird,spending167billionU.S.dollarsonR&D.ReadmoreNote(s):Worldwide;2000to2022Source(s):OECDLeadingcountriesbygrossresearchanddevelopment(R&D)expenditureworldwidein2022(inbillionU.S.dollars)LeadingcountriesbyR&Dspendingworldwide2022Expenditureinbillion300U.S.dollars4000100200500600700800UnitedStates*China***761.58620.38Italy*Japan180.46180.46Germany*SouthKoreaUnitedKingdom*,***France*131.83119.6484.2263.9755.0340.32TaiwanRussia**,****Turkey36.9932.4431.68Canada*Israel**6Description:TheUnitedStatesistheleadingcountryworldwideintermsofspendingonresearchanddevelopment(R&D),withR&Dexpenditureexceeding760billionpurchasingpowerparity(U.S.dollars.Chinaisinvestedabout620billionU.S.dollarsintoR&D.ReadmoreNote(s):Worldwide,OECD;2020to2022;Derivedfrompurchasingpowerparitycalculations,constantprices;*Provisionalvalue.

**Estimates.

***Datafrom2021.

****Datafrom2020.

ReadmoreSource(s):OECDLeadingcountriesbyresearchanddevelopment(R&D)expenditureasshareofgrossdomesticproduct(GDP)worldwidein2022LeadingcountriesbyR&DspendingasshareofGDPglobally2022ShareofGDP0%1%2%3%4%5%6%Israel**SouthKoreaTaiwan6.02%5.21%3.96%UnitedStates*Belgium*Japan3.59%3.41%3.41%3.41%SwedenSwitzerland***Austria*3.31%3.2%3.13%2.96%2.89%Germany*FinlandDenmark*Iceland2.66%7Description:In2022,Israelinvestedsixpercentofthecountry'sgrossdomesticproduct(GDP)intoresearchanddevelopment,thehighestworldwide.InSouthKorea,theexpenditureonR&DreachedoverfivepercentofitsGDP.

ReadmoreNote(s):Worldwide,OECD;2020to2022;Derivedfrompurchasingpowerparitycalculations;*Provisionalvalue.

**Estimate.

***Datafrom2021.

****Datafrom2020.

Valuesareadjustedforpurchasingpowerparity(Source(s):OECDThedefinitiondiffers[...]

ReadmoreRankingofthecompanieswiththehighestspendingonresearchanddevelopmentworldwidein2022(inbillionU.S.dollars)Companieswiththehighestspendingonresearchanddevelopment2022Expenditure(inbillionU.S.dollars)01020304050607080AmazonMeta73.2135.34Alphabet28.8Apple26.25HuaweiMicrosoft23.222.7Samsung18.1717.7TencentHoldingsIntelCorp.VolkswagenAlibaba17.5317.117RocheJohnson&Johnson15.1514.68Description:Amazonspentthemostonresearchanddevelopmentinthefiscalyear2022,withover73billionU.S.dollars.Meta,Alphabet,Apple,andHuaweiroundedoutthetopfiveofcompanieswiththehighestR&Dspendingthatyear.

ReadmoreNote(s):Worldwide;2022Source(s):InsiderMonkey;MacrotrendsPercentageofspendingonresearchanddevelopmentoftotalrevenuein2021,byindustrialsectorIndustrysectors-expenditureonresearchanddevelopment2021R&Dshareoftotalrevenue4%

6%0%2%8%10%12%14%HealthindustriesICTservices12.4%9.3%ICTproducts7%Automobiles&othertransportsTotal4.9%4.7%AerospaceanddefenseFinancial3.9%2.7%2.6%OthersIndustrials2.5%Chemicals2.4%Construction2.3%Energy0.5%9Description:Thisstatisticrepresentsthepercentageofexpenditureonresearchanddevelopmentoftotalrevenuein2021,byindustrialsector.Thedatawasgeneratedfromthenumbersofthe2,500topcompaniesworldwide.In2021,spendingonresearchanddevelopmentaccountedformorethan12percentofthetotalrevenueinthehealthindustries.ReadmoreNote(s):WorldwideSource(s):EFPIA;EuropeanCommission;R&DScoreboardDistributionofresearchanddevelopment(R&D)spendingworldwidein2021,byenduseDistributionofR&Dexpenditureglobally2021,byenduseCapitalspending13%Outsourcing12%Salaries30%Suppliesandconsumables13%Overhead12%Materials20%10Description:Researchersalariesmadeupthelargestshareofthespendingofresearchanddevelopmentcompaniesworldwidein2021,reaching30percent.Thisfigureisonlyexpectedtoincreaseinthecomingyearsfollowingtherisingglobalinflation.Materialcostsmadeupthesecondhighestshareofexpensesat20percent.ReadmoreNote(s):Worldwide;Spring2022;R&DWorldreadesSource(s):R&DWORLDCHAPTER

02IndustryandgeographicdistributionMostinnovativecountriesin2023,byglobalinnovationindexscoreMostinnovativecountriesbyGIIscore2023OverallGIIscore(0-100)01020304050607080SwitzerlandSwedenUnitedStatesUnitedKingdomSingaporeFinland67.664.263.562.461.561.260.4NetherlandsGermanyDenmarkKoreaRep.France58.858.758.656China55.3Japan54.612/statistics/1102558/most-innovative-countries-gii-scoreAccordingtothetheGlobalInnovationIndex(GII)in2023,Switzerlandwasthemostinnovativecountryintheworld,withanoverallGIIscoreof67.6outof100.Swedenrankedsecond,withascoreof64.2,whiletheUnitedStatesfollowedrightbehind.ReadmoreNote(s):Worldwide;2023Source(s):WIPOShareofanddevelopment(R&D)spendingin2022,byregionandindustryR&Dspendingsharesbyregionandindustry2022EUUSAChinaJapanRestoftheworld120%100%80%60%40%20%0%AerospaceandDefenseAutomobiles&othertransportChemicalsConstruction&materialsEnergyFinancialIndustrialsOthers13Description:In2022,companiesbasedintheUnitedStatesandtheEUstoodbehindthehighestglobalspendingonresearchanddevelopment(R&D)withinaerospaceanddefense,accountingformorethan80percentofglobalspending.Moreover,ChinacompletelydominatesR&Dspendingonconstruction,amountingto85percentofworldwidespending.Lookingatsinglecompanies,AmazonspentthehighestamountonR&Din2022.ReadmoreNote(s):Worldwide;2022Source(s):EuropeanCommissionPercentageofanddevelopmentspendingin2022,byindustryPercentageofglobalR&Dspending,byindustry2022AerospaceandDefense1.8%Automobiles&othertransport14.0%SoftwareandInternet21.9%Chemicals2.3%Construction2.8%Energy1.8%Financial1.9%Other6.9%Healthindustries22.0%Hardwareproducers24.1%14Description:In2022,thehighestshareofresearchanddevelopmentspending(R&D)wasmadewithinthehardwaretechnologyproducingindustry,accountingforatotalofnearly23percentoftheglobalR&Dspending.Thehealthsectorandsoftwareproducersfollowedinsecondatnearly21percenteach.Intotal,globalR&Dspendingreached2.5trillionU.S.dollarsin2022.ReadmoreNote(s):Worldwide;2022Source(s):EuropeanCommissionDistributionofthe2,500leadinganddevelopment(R&D)spendingcompaniesin2022,byregionandindustryDistributionofR&Dspendingcompaniesbyregionandindustry2022USAEUJapanChinaRestoftheworld120%100%80%60%40%20%0%Aerospace

Automobiles

Chemicals

Construction

EnergyandDefense

&othertransportFinancialHealthICTICTservices

IndustrialsOthersTotalIndustries

producers15Description:Ofthe2,500leadingresearchanddevelopment(R&D)investingcompaniesin2022,thelargestsharewithinaerospaceanddefense,health,andICTserviceswasbasedintheUnitedStates.Moreover,ChinesecompaniesdominatesR&Dspendingonconstruction,amountingtomorethanhalfoftheeladingcompaniesworldwide.Furthermore,companiesbasedintheEUmadeupthelargestsharewithinenergyandfinancialservices.Lookingatsinglecompanies,Alphabetspent[...]

ReadmoreNote(s):Worldwide;2022Source(s):EuropeanCommissionCHAPTER

03Pharmaceuticals&healthcareTotalglobalspendingonpharmaceuticalresearchanddevelopmentfrom2014to2028(inbillionU.S.dollars)TotalglobalpharmaceuticalR&Dspending2014-20283503002503022962892812722622492442111942001501005018517116115114502014201520162017201820192020202120222023*2024202520262027202817Description:In2022,researchanddevelopmentspendinginthepharmaceuticalindustrytotaledsome244billionU.S.dollarsglobally.Forcomparison,R&Dexpenditurestotaled137billiondollarsin2012.PharmaceuticalR&Dincludesallstepsfromtheinitialresearchofdiseaseprocesses,thecompoundtestingoverpre-clinical,andallclinicaltrialstages.Atacertainpointintheprocess–mostlyduringthepre-clinicalphase–agovernmentalauthorityisinvolvedtooverview,regulate,andultimately[...]

ReadmoreNote(s):Worldwide;asofAugust2023;*Allvaluesareprojectedfrom2023on.ReadmoreSource(s):EvaluateDistributionofpharmaceuticalR&Dcompaniesworldwideasof2023and2024,bycountryDistributionofpharmaceuticalR&Dcompaniesbyregion2023vs.2024ShareofR&Dcompanies2024

202339%UnitedStatesChina43%16%15%13%13%RestofEuropeRestofAsiaPacificUnitedKingdomFrance15%11%5%5%3%3%3%Japan3%3%Canada4%2%2%Germany1%LatinAmericaandAfrica1%18Description:ThisstatisticshowsthedistributionofpharmaceuticalR&Dcompaniesworldwidebycountryorregion,asofJanuary2023andJanuary2024.Asof2024,39percentofallpharmaceuticalR&DcompanieswereheadquarteredintheUnitedStates,comparedto43percentoneyearbefore..ReadmoreNote(s):Worldwide;asofJanuary2023andJanuary2024Source(s):CitelineLeading50globalpharmaceuticalcompaniesbyprescriptionsalesandR&Dspendingin2022(inbillionU.S.dollars)Top50pharmaceuticalcompanies-RxsalesandR&Dspending2022Sales/spendinginbillionU.S.dollarsResearchanddevelopmentspending20

30

40Prescriptionsales50

6001070809010012.38Pfizer(U.S.)AbbVie(U.S.)91.36.4456.1814.14Johnson&Johnson(U.S.)Novartis(Switzerland)Merck&Co.(U.S.)Roche(Switzerland)BristolMyersSquibb(U.S.)AstraZeneca(UK)Sanofi(France)50.179.0950.0849.6311.8414.7847.9145.4210.029.57.166.344.74.974340.3538.25GSK(UK)Takeda(Japan)GileadSciences(U.S.)29.6926.6219Description:Thetop50pharmaceuticalcompaniesbyprescriptionsalesin2022–andtheirresearchanddevelopment(R&D)spending–includedbignamessuchasPfizer,Novartis,andAbbVie.Duringthatyear,Pfizer'sRxsaleswereapproximately91billiondollars.Thus,theAmericanpharmagiantwasboththelargestpharmaceuticalcompanybasedonpurepharmarevenueworldwideandthethirdrankedpharmaceuticalcompanybasedonR&Dspending.Pfizerspent12.38billionU.S.dollarson[...]

ReadmoreNote(s):WorldwideSource(s):Evaluate(EvaluatePharma);PharmaceuticalExecutive;Varioussources(companydata)Selectleadingglobalbiotechnologycompanies'R&Dexpenditurein2022(inmillionU.S.dollars)Topglobalbiotechcompanies-R&Dexpenditure2022R&DexpenditureinmillionU.S.dollars02,0004,0006,0008,00010,00012,00014,00016,00018,00020,000Roche(Switzerland)*BristolMyersSquibb(U.S.)AbbVie(U.S.)17,3489,5096,510GileadSciences(U.S.)Amgen(U.S.)4,9774,434Regeneron(U.S.)3,5933,452NovoNordisk(Denmark)**Moderna(U.S.)3,295Vertex(U.S.)2,5402,231Biogen(U.S.)20Description:ThisstatisticdepictsR&Dexpendituresofsomeofthegloballeadingcompaniesinbiotechnologyin2022.Inthatyear,DanishbiopharmaceuticalmanufacturerNovoNordiskspentaround3.4billionU.S.dollarsonresearchanddevelopment.

ReadmoreNote(s):WorldwideSource(s):PharmaceuticalExecutive;VarioussourcesDistributionoftotalglobalfundingonresearchanddevelopmentforselecteddiseasesfrom2020to2022DistributionoftotalfundingonR&Dforselecteddiseases2020-2022202035%202135%202234%18%15%4%HIV/AIDSTuberculosis17%17%Malaria16%15%DiarrhoealdiseasesKinetoplastidaWormsandflukesDengue3.8%3.7%1.9%1.9%1.9%1.7%0.5%0.4%0.4%0.2%3.3%3.2%2.1%1.9%1.7%1.5%0.4%0.4%0.4%0.2%3.2%2.6%2.1%2%SalmonellainfectionsBacterialpneunomia/meningitisHepatitisB1.2%0.8%0.5%0.4%0.3%SnakebiteenvenomingHepatitisCLeprosy21Description:Thestatisticshowsthedistributionoftotalglobalfundingonresearchanddevelopmentforselecteddiseasesfrom2020to2022.In2022,theshareoffundingonresearchanddevelopmentonHIVandAIDSamountedto34percent.

ReadmoreNote(s):WorldwideSource(s):PolicyCuresAllocationofresearchanddevelopmentinvestmentsinpharmaceuticalindustryin2021,byfunctionAllocationofR&Dinvestmentsinpharmaceuticalindustrybyfunction2021PercentageofR&Dinvestments0%5%10%9%15%20%25%30%35%40%45%50%55%Pre-human/pre-clinicalClinicaltrials14.7%49.2%PhaseI*PhaseII*11.5%PhaseIII*28.7%Approval4.9%Pharmacovigiliance(PhaseIV)Uncategorized12.9%18.2%22Description:Thisstatisticdisplaysthepharmaceuticalindustry'sresearchanddevelopmentinvestmentallocationbyselectfunctionsin2021.Thepharmaceuticalindustryspent14.7percentofresearchanddevelopmentinvestmentsduringpre-humanorpre-clinicalstages.ReadmoreNote(s):WorldwideSource(s):EFPIA;PhRMAGlobaltop10pharmaceuticalcompaniesbasedonprojectedR&Dspendingin2026(inbillionU.S.dollars)GlobaltoppharmaceuticalcompaniesbasedonR&Dspending2026R&DspendinginbillionU.S.dollars024681012141416RocheJohnson&JohnsonMerck&Co12.211.4Pfizer10.5Novartis10Bristol-MyersSquibbAstraZenecaEliLilly98.68.17.9GlaxoSmithKlineAbbVie7.523Description:In2026,Swiss-basedRocheisprojectedtospend14billionU.S.dollarsonpharmaceuticalresearchanddevelopment.OthercompanieswithhighprojectedR&DexpendituresareMerck,Pfizer,andJohnson&Johnson.

ReadmoreNote(s):Worldwide;asofMay2021Source(s):EvaluateCHAPTER

04Software,computing,communication&electronicsInformationandcommunicationtechnology(ICT)researchanddevelopment(R&D)expenditureworldwidein2022,bycountryorregion(inbillioneuros)ICTresearchanddevelopmentexpenditureinworldwide2022,bycountryHardwareSoftware30025020015010050285.3259.3180.6120.959.85238.73220.817.2EU10.712.1RestoftheWorld0WorldwideUnitedStatesChinaJapan25Description:Intotal,researchanddevelopment(R&D)spendingoninformationandcommunicationtechnologyworldwideamountedto545billioneurosin2022.Ofthese,285billionswerespentbyhardwarecompanies,ofwhich121billioneuroswerespentbyfirmsbasedintheUntiedStates.Moreover,U.S.basedfirmsstoodbehindovertwothirdsofR&Dspendingwithinsoftwareproductsworldwide.ChineseHuaweiwasthehardwareproducerwiththelargestspending,whereasAlphabetspentthe[...]

ReadmoreNote(s):Worldwide,UnitedStates;2022Source(s):EuropeanCommissionIndustrialresearchanddevelopment(R&D)spendingintheICTsectorworldwidefrom2020to2022(inbillionU.S.dollars)IndustrialR&DspendingintheICTsectorworldwide2020-2022300274264252.125020015010050020202021202226/statistics/1346784/global-industrial-randd-spending-in-the-ict-sectorIndustrialresearchanddevelopment(R&D)spendingintheICTsectorregisteredasteadyincreaseovertheperiodunderconsideration.In2022,R&Dspendingamountedto274billionU.S.dollars,registeringanincreaseofnearlyfourpercentsince2021.ReadmoreNote(s):WorldwideSource(s):R&DWORLD;Schonfeld&AssociatesRankingoftheleadingtechnologyhardware&equipmentcompanieswiththehighestspendingonresearchanddevelopment(R&D)worldwidein2022(inmillioneuros)Technologyhardware&equipmentcompanieswiththehighestspendingonR&D2022Expenditureinmillioneuros05,00010,00015,00020,00025,00024,61230,000Apple(UnitedStates)HuaweiInvestment&Holding(China)SamsungElectronics(SouthKorea)IntelCorporation(UnitedStates)QUALCOMM(UnitedStates)20,92518,43516,4347,6826,881Nvidia(UnitedStates)TaiwanSemiconductors(Taiwan)AdvancedMicroDevices(UnitedStates)ASMLHolding(Netherlands)4,9854,6923,0721,977ContemporaryAmperexTechnology(China)27Description:In2022,thetechnologyhardwaremanufacturerthatspentthemostonresearchanddevelopment(R&D)wastheAmericangiantApple,withanR&Dexpenditureofnearly25billioneuros.ClosebehindcameChineseHuaweiwithaspendingof21billioneuros,followedbySamsung.TheEuropeanhardwarecompanywiththehighestR&Dspendingin2022wasASML.ReadmoreNote(s):Worldwide;2022Source(s):EuropeanCommissionResearchanddevelopment(R&D)spendingintheICTsectorworldwidefrom2020to2022,bycompany(inbillionU.S.dollars)R&DspendingintheICTsectorworldwide2020-2022,bycompany202020212022504540353025201510546.543.139.813430.227.323.520.52018.6718.617.517.215.25Intel14.50AmazonAlphabet/GoogleAppleComputerMicrosoft28Description:Since2021,Amazon'sresearchanddevelopment(R&D)spendingintheICTsectorwasvaluedatover43billionU.S.dollars.ItwasfollowedbyGoogle,withR&Dspendingworth34billionU.S.dollarsin2022.

ReadmoreNote(s):WorldwideSource(s):R&DWORLD;Schonfeld&AssociatesRevenuesfromtheartificialintelligence(AI)softwaremarketworldwidefrom2018to2025(inbillionU.S.dollars)Artificialintelligencesoftwaremarketrevenueworldwide2018-20251401201008012694.4170.946051.274020034.8722.5914.6910.120182019*2020*2021*2022*2023*2024*2025*29Description:Theglobalartificialintelligence(AI)softwaremarketisforecasttogrowrapidlyinthecomingyears,reachingaround126billionU.S.dollarsby2025.TheoverallAImarketincludesawidearrayofapplicationssuchasnaturallanguageprocessing,roboticprocessautomation,andmachinelearning.ReadmoreNote(s):Worldwide;2018to2020;*ForecastReadmoreSource(s):OmdiaCHAPTER

05Automotive,Aerospace&DefenseTotalanddevelopment(R&D)spendingonautomobilesandothertransportin2022,byregion(inbillioneuros)TotalR&Dspendingonautomotiveworldwide2022,byregion1601451401201008061.1604020030.226.3USA18.19.2TotalEUChinaJapanRestoftheWorld31Description:GlobalR&Dspendingintheautomotivesectorreached145billioneurosin2022.CompaniesbasedintheEuropeanUnionstoodbehindthelargestshareofthespending,amountingtomorethan60billioneuros.Japanesecompaniesspentthesecondlargestsumonresearch&developmentthatyear.Breakingdownbycompany,Volkswagenwasthelargestsinglespender.ReadmoreNote(s):Worldwide;2022*;*Figuresfromfiscalyear.Showsdataforthe2,500largestR&Dspendingcompaniesworldwide.ReadmoreSource(s):EuropeanCommissionLeadingautomotivefirmsbyresearchanddevelopmentspendingworldwideinFY2021(inbillionU.S.dollars)GlobalR&Dspending:keycompaniesintheautomotivesector2021SpendinginbillionU.S.dollars024681012141618Volkswagen*Mercedes-BenzGroup*GeneralMotorsFord15.589.17.97.67.6Toyota**32Description:Inthe2021fiscalyear,U.S.-basedcarmakerFordreportedresearchanddevelopmentcostsofaround7.6billionU.S.dollars.Incontrast,Germany'sVolkswagenspentaround15.6billionU.S.dollarsinR&Dexpenditure.

ReadmoreNote(s):Worldwide;FY2021;*ThesefigureshavebeenconvertedfromeurostoU.S.dollarsatthefollowingrate,correctasofSeptember15,2021:1EUR=1USD;**thisfigurehasbeenconvertedfromJapaneseyentoU.S.dollarsatthefollowing[...]

ReadmoreSource(s):

VarioussourcesTotalanddevelopment(R&D)spendingonaerospaceanddefensein2022,byregion(inbillioneuros)TotalR&Dspendingonaerospaceanddefenseworldwide2022,byregion2521.420159.41058.7EU2.90.400TotalUSAChinaJapanRestoftheWorld33Description:Intotal,21.4billioneuroswerespentonresearchanddevelopment(R&D)withinaerospaceanddefensebythe2,500largestspendersworldwidein2022.Ofthese,9.4billionswerespentintheUnitedStates,and8.7billionsintheEuropeanUnion.Boeingwasthecompanywiththehighestspending.ReadmoreNote(s):Worldwide;2022Source(s):EuropeanCommissionLeadinggovernmentspendingondefenseresearchanddevelopment(R&D)amongOECDmembersin2021,bycountry(inshareofR&Dbudget))GovernmentR&DspendingondefenseinOECDcountries2021ShareoftotalGBARD*budget0%5%10%15%20%25%30%35%40%45%50%UnitedStatesOECDtotal***Turkey47.2%18.5%15.6%15.6%KoreaRep.France***10.7%UnitedKingdom*****Australia**Hungary7.7%6.4%6.4%PolandGermany4.4%4.2%NorwayNetherlandsSlovakia3.2%3.1%2.2%34Description:IntheOECD,theUnitedStatesspendnearlyhalfofitsgovernmentresearchanddevelopmentbudgetondefense.TurkeyandJapanfollowedbehindwithnearly16percent.Onaverage,18.5percentoftheR&DspendingofOECDcountrieswasbudgetedforthedefensesector,butthehighspendingoftheU.S.hasahighinfluenceonthisfigure.ReadmoreNote(s):Worldwide,OECD;2021;*GBARDstandsforGovernmentbudgetallocationsforR&D.**Provisionalvalue.***estimates.br>****Definitiondiffers.*****Numbersarefrom2020.

ReadmoreSource(s):OECDCHAPTER

06Chemicals,Energy&IndustrialManufacturingTotalanddevelopment(R&D)spendingonchemicalsin2022,byregion(inbillioneuros)TotalR&Dspendingonchemicalsworldwide2022,byregion3026.9252015107.65.554.54.350TotalEUUSAChinaJapanRestoftheWorld36Description:anddevelopment(R&D)spendinginthechemicalssectorisanticipatedtohavereachedatotalof27billioneurosin2022.CompaniesinJapanspentthelargestsum,reaching7.6billioneuros,followedbytheEuropeanUnionat5.5billions.ReadmoreNote(s):Worldwide;2022Source(s):EuropeanCommissionTotalanddevelopment(R&D)spendingonenergyin2022,byregion(inbillioneuros)TotalR&Dspendingonenergyworldwide2022,byregion2521.32015107.95.853.92.90.90TotalEUUSAChinaJapanRestoftheWorld37Description:GlobalR&Dspendingintheenergysectoramountedtoover21billioneurosin2022.ThehighestsumswerespentintheEuropeanUnionandChina,with5.8andnearlyeightbillioneurosrespectively.

ReadmoreNote(s):Worldwide;2022Source(s):EuropeanCommissionTotalanddevelopment(R&D)spendingonindustrialsin2022,byregion(inbillioneuros)TotalR&Dspendingonindustrialsworldwide2022,byregion7062.86050403024.12013.29.48.91007.2TotalEUUSAChinaJapanRestoftheWorld38Description:Atotalamountof63billioneuroswerespentonresearchanddevelopment(R&D)withintheindustrialsectorin2022.ThehighestsumwasspentbyChinesecompaniesatover24billioneuros,followedbycompaniesbasedintheEuropeanUnion.ThelargestsinglespenderwasGermanBASF.ReadmoreNote(s):Worldwide;2022Source(s):EuropeanCommissionRankingoftheleadingenergy,ch

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。

評論

0/150

提交評論